Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NATH BIO-GENES (INDIA) LTD.

NSE : NATHBIOGENBSE : 537291ISIN CODE : INE448G01010Industry : AgricultureHouse : Private

BSE159.204.95 (+3.21 %)

PREV CLOSE ( ) 154.25

OPEN PRICE ( ) 155.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 10878

TODAY'S LOW / HIGH ( )154.70 162.00

52 WK LOW / HIGH ( )141.1 264.5

NSE159.164.99 (+3.24 %)

PREV CLOSE( ) 154.17

OPEN PRICE ( ) 157.80

BID PRICE (QTY) 159.16 (2)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 34883

TODAY'S LOW / HIGH( ) 154.41 162.45

52 WK LOW / HIGH ( )137.55 264.31

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-09 2000

Management Info

Satish Kagliwal - Chairman Satish Kagliwal - Managing Director

Registered Office

Address Nath House, Nath Road,P B No 318,,
Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431005

Phone 0240-6645555

Email info@nathseeds.com / investor@nathbiogenes.com

Website www.nathbiogenes.com

Registrars Details

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai

Listing : BSE, NSE

NEWS

19Oct Nath Bio-Genes (India) submits analyst
Nath Bio-Genes (India) has informed that the Company will hold Earning C..

17Oct Nath Bio-Genes (India) informs about b
Nath Bio-Genes (India) has informed that the meeting of the Board of Dir..

17Aug Nath Bio-Genes (India) informs about o
Nath Bio-Genes (India) has informed that the 31st AGM of the Members of..

17Aug Nath Bio-Genes (India) informs about u
Nath Bio-Genes (India) has informed that Annual General Meeting of the C..

14Jun Nath Bio-Genes (India) informs about l
Nath Bio-Genes (India) has informed that share certificate is reported m..

Financials

Rs. in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	26.54	401.770000000001
Gross Profit	37.94	386.740000000001
Operating Profit	79.86	510.370000000001
Net Sales	368.73	3326.25

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bombay Burmah Trdg. (BSE) 1888.90 (6.91%)	M.Cap ( in Cr)13179.21
Kaveri Seed (BSE) 1287.55 (5.54%)	M.Cap ( in Cr)6623.04
Naturite Agro Prod. (BSE) 312.00 (4.75%)	M.Cap ( in Cr)165.24
JK Agri Genetics (BSE) 344.00 (1.30%)	M.Cap ( in Cr)159.51
Hind Agrigenetics (BSE) 70.87 (4.99%)	M.Cap ( in Cr)31.18

Shareholding Pattern

	NON-INSTITUTION	49.84%
	PROMOTERS	45.6%
	MUTUAL FUNDS/UTI	4.37%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Aditya Birla SL Pur...	0.25

Risk Disclosures on Derivatives

Smart Quotes

NATH BIO-GENES (INDIA) LTD.